Clinical Trial Update: Vandetanib Gemcitabine Or Placebo Plus Gemcitabine Or Vandetanib Monotherapy In Advanced Biliary Tract Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated vandetanib with gemcitabine, vandetanib monotherapy, or gemcitabine with placebo in advanced biliary tract cancers, with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ampullary Carcinoma
• Biliary Tract Cancer
• Cancer of the Extrahepatic Bile Duct
• Gallbladder Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Vandetanib (vandetanib)

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Biliary Tract Cancer, Gallbladder Cancer | Phase 2 | Status: COMPLETED | Results posted: 2013-11-28